Perioperative adjuvant biotherapy in high-risk resected cutaneous melanoma: the results of 5 years of follow-up.
Melanoma Res., Oct;17(5):310-5 (2007)
Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.
Cancer Biother. Radiopharm., Jun;23(3):285-91 (2008)
Dendritic cell counts in the peripheral blood of healthy adults.
Am. J. Hematol., Apr;78(4):314-5 (2005)
In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma.
J. Clin. Immunol., Jul;26(4):331-8 (2006)
Diminished dose minimally invasive radioguided parathyroidectomy: a case for radioguidance.
Am Surg., Jul;73(7):669-72; discussion 673 (2007)
The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
J. Am. Coll. Surg., Sep;197(3):403-7 (2003)
Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
Int. J. Oncol., Aug (2012)
Infected transplant pancreatic pseudocyst managed by catheter drainage and pancreatico-ileostomy.
Nephrol. Dial. Transplant., Apr;12(4):827-30 (1997)
Divided gastric bypass: a fifteen-year experience.
Am Surg., Jan;64(1):62-5; discussion 65-6 (1998)
Prophylactic jejunostomy: a reappraisal.
Surgery., Oct;124(4):715-9; discussion 719-20 (1998)
Granular cell tumors of the biliary tree.
Surgery., Jul;128(1):113-5 (2000)